Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals
Open Access
- 14 September 2020
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 26 (7) , 3292-3301
Abstract
Ketamine improves motivation-related symptoms in depression but simultaneously elicits similar symptoms in healthy individuals, suggesting that it might have different effects in health and disease. This study examined whether ketamine affects the brain’s fronto-striatal system, which is known to drive motivational behavior. The study also assessed whether inflammatory mechanisms—which are known to influence neural and behavioral motivational processes—might underlie some of these changes. These questions were explored in the context of a double-blind, placebo-controlled, crossover trial of ketamine in 33 individuals with treatment-resistant major depressive disorder (TRD) and 25 healthy volunteers (HVs). Resting-state functional magnetic resonance imaging (rsfMRI) was acquired 2 days post-ketamine (final sample: TRD n = 27, HV n = 19) and post-placebo (final sample: TRD n = 25, HV n = 18) infusions and was used to probe fronto-striatal circuitry with striatal seed-based functional connectivity. Ketamine increased fronto-striatal functional connectivity in TRD participants toward levels observed in HVs while shifting the connectivity profile in HVs toward a state similar to TRD participants under placebo. Preliminary findings suggest that these effects were largely observed in the absence of inflammatory (C-reactive protein) changes and were associated with both acute and sustained improvements in symptoms in the TRD group. Ketamine thus normalized fronto-striatal connectivity in TRD participants but disrupted it in HVs independently of inflammatory processes. These findings highlight the potential importance of reward circuitry in ketamine’s mechanism of action, which may be particularly relevant for understanding ketamine-induced shifts in motivational symptoms.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (ZIAMH002857, ZIAMH002857, ZIAMH002857, ZIAMH002857, ZIAMH002857, ZIAMH002857)
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
This publication has 76 references indexed in Scilit:
- Frontostriatal functional connectivity in major depressive disorderBiology of Mood & Anxiety Disorders, 2011
- Cortico-basal ganglia circuitry: a review of key research and implications for functional connectivity studies of mood and anxiety disordersBrain Structure and Function, 2010
- Inflammation-Induced Anhedonia: Endotoxin Reduces Ventral Striatum Responses to RewardBiological Psychiatry, 2010
- Reduced capacity to sustain positive emotion in major depression reflects diminished maintenance of fronto-striatal brain activationProceedings of the National Academy of Sciences, 2009
- The Reward Circuit: Linking Primate Anatomy and Human ImagingNeuropsychopharmacology, 2009
- Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual ActionNeuropsychopharmacology, 2009
- Neurocircuitry of Mood DisordersNeuropsychopharmacology, 2009
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979